GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Grifols GRF.MC · EUR

Health Care · BME · 🇪🇸 Spain

Compare

11.38

+1.16%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Grifols — daily BME:GRF Delayed
Market value
€7.73bn
Last close × shares
Volume
2.2m
Shares, 9 Nov 2026
Price to earnings
15.3
Dividend yield
1.34%

About Grifols

Its shares trade on BME under the ticker GRF.MC. It has been listed since 17 May 2006. In the fiscal year to 31 December 2025, it reported revenue of €7.52bn and net income of €401.9m. At that date it held total assets of €19.71bn and shareholders' equity of €5.27bn.

Grifols SA engages in the production of plasma derivatives. The company is headquartered in Barcelona, Barcelona. The company went IPO on 2006-05-17. The company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.

Figures and description from our data supplier, not checked against the company's own report.

More about Grifols →

Latest on Grifols

Our reporting

Next results

4 Mar 2027

Due on 4 Mar 2027. Analysts expect earnings of 0.30 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Grifols's ticker?

Grifols trades as GRF.MC on BME, under ISIN ES0171996087.

What was Grifols's last closing price?

11.38 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Grifols next report results?

Results are expected on 4 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.